These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 10753059)

  • 1. Isolation of monoclonal antibodies directed against the V protein of human parainfluenza virus type 2 and localization of the V protein in virus-infected cells.
    Nishio M; Tsurudome M; Ito M; Kawano M; Kusagawa S; Komada H; Ito Y
    Med Microbiol Immunol; 1999 Nov; 188(2):79-82. PubMed ID: 10753059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the sequences responsible for nuclear targeting of the V protein of human parainfluenza virus type 2.
    Watanabe N; Kawano M; Tsurudome M; Kusagawa S; Nishio M; Komada H; Shima T; Ito Y
    J Gen Virol; 1996 Feb; 77 ( Pt 2 )():327-38. PubMed ID: 8627237
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigenic diversity of human parainfluenza virus type 1 isolates and their immunological relationship with Sendai virus revealed by using monoclonal antibodies.
    Komada H; Kusagawa S; Orvell C; Tsurudome M; Nishio M; Bando H; Kawano M; Matsumura H; Norrby E; Ito Y
    J Gen Virol; 1992 Apr; 73 ( Pt 4)():875-84. PubMed ID: 1378879
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between nucleocapsid protein (NP) and phosphoprotein (P) of human parainfluenza virus type 2: one of the two NP binding sites on P is essential for granule formation.
    Nishio M; Tsurudome M; Kawano M; Watanabe N; Ohgimoto S; Ito M; Komada H; Ito Y
    J Gen Virol; 1996 Oct; 77 ( Pt 10)():2457-63. PubMed ID: 8887478
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Graf1 Controls the Growth of Human Parainfluenza Virus Type 2 through Inactivation of RhoA Signaling.
    Ohta K; Goto H; Matsumoto Y; Yumine N; Tsurudome M; Nishio M
    J Virol; 2016 Oct; 90(20):9394-405. PubMed ID: 27512058
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human parainfluenza virus type 2 phosphoprotein: mapping of monoclonal antibody epitopes and location of the multimerization domain.
    Nishio M; Tsurudome M; Ito M; Watanabe N; Kawano M; Komada H; Ito Y
    J Gen Virol; 1997 Jun; 78 ( Pt 6)():1303-8. PubMed ID: 9191922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mapping of domains on the human parainfluenza virus type 2 nucleocapsid protein (NP) required for NP-phosphoprotein or NP-NP interaction.
    Nishio M; Tsurudome M; Ito M; Kawano M; Kusagawa S; Komada H; Ito Y
    J Gen Virol; 1999 Aug; 80 ( Pt 8)():2017-2022. PubMed ID: 10466799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An anti-fusion regulatory protein-1 monoclonal antibody suppresses human parainfluenza virus type 2-induced cell fusion.
    Okamoto K; Tsurudome M; Ohgimoto S; Kawano M; Nishio M; Komada H; Ito M; Sakakura Y; Ito Y
    J Gen Virol; 1997 Jan; 78 ( Pt 1)():83-9. PubMed ID: 9010289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping of domains on the human parainfluenza type 2 virus P and NP proteins that are involved in the interaction with the L protein.
    Nishio M; Tsurudome M; Ito M; Ito Y
    Virology; 2000 Aug; 273(2):241-7. PubMed ID: 10915594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extensive antigenic diversity among human parainfluenza type 2 virus isolates and immunological relationships among paramyxoviruses revealed by monoclonal antibodies.
    Tsurudome M; Nishio M; Komada H; Bando H; Ito Y
    Virology; 1989 Jul; 171(1):38-48. PubMed ID: 2545038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of human parainfluenza virus 4 nucleocapsid-like particles in yeast and their use for detection of virus-specific antibodies in human serum.
    Bulavaitė A; Lasickienė R; Tamošiūnas PL; Simanavičius M; Sasnauskas K; Žvirblienė A
    Appl Microbiol Biotechnol; 2017 Apr; 101(7):2991-3004. PubMed ID: 28102432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding of the V proteins to the nucleocapsid proteins of human parainfluenza type 2 virus.
    Watanabe N; Kawano M; Tsurudome M; Nishio M; Ito M; Ohgimoto S; Suga S; Komada H; Ito Y
    Med Microbiol Immunol; 1996 Sep; 185(2):89-94. PubMed ID: 8884740
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monoclonal antibodies to human parainfluenza virus type 1 detect major antigenic changes in clinical isolates.
    Henrickson KJ
    J Infect Dis; 1991 Dec; 164(6):1128-34. PubMed ID: 1659598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of human monoclonal antibodies to rabies.
    Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
    Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of recombinant nucleoprotein-based diagnostic systems for Lassa fever.
    Saijo M; Georges-Courbot MC; Marianneau P; Romanowski V; Fukushi S; Mizutani T; Georges AJ; Kurata T; Kurane I; Morikawa S
    Clin Vaccine Immunol; 2007 Sep; 14(9):1182-9. PubMed ID: 17634509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison between parainfluenza virus type 2 and simian virus 5: monoclonal antibodies reveal major antigenic differences.
    Randall RE; Young DF
    J Gen Virol; 1988 Aug; 69 ( Pt 8)():2051-60. PubMed ID: 2841416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Searching for MHC-restricted anti-viral antibodies: antibodies recognizing the nucleoprotein of influenza virus dominate the serological response of C57BL/6 mice to syngeneic influenza-infected cells.
    Tamminen WL; Wraith D; Barber BH
    Eur J Immunol; 1987 Jul; 17(7):999-1006. PubMed ID: 3497045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and application of monoclonal antibodies against avian influenza virus nucleoprotein.
    Yang M; Berhane Y; Salo T; Li M; Hole K; Clavijo A
    J Virol Methods; 2008 Feb; 147(2):265-74. PubMed ID: 18006085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conformational maturation of the nucleoprotein synthesized in influenza C virus-infected cells.
    Sugawara K; Muraki Y; Takashita E; Matsuzaki Y; Hongo S
    Virus Res; 2006 Dec; 122(1-2):45-52. PubMed ID: 16870298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.